Building Your Child's Care Team
At a Glance
Children with CFC3 often need a coordinated care team, led by genetics and tailored to heart, development, feeding, vision, hearing, and infection concerns. Before surgery or sedation, the pediatric anesthesiologist should review the child’s heart, airway, seizure, and medication history.
Navigating a diagnosis of Cardiofaciocutaneous Syndrome 3 (CFC3) requires more than a single doctor; it requires a “medical home” of specialists who understand how the MAP2K1 mutation affects different parts of the body. Because CFC is a multisystem condition, early and continuous multidisciplinary care is the standard for ensuring your child meets their full potential [1][2].
The Core Specialty Team
A child with CFC3 typically needs evaluations with several pediatric subspecialists. Think of this list as a menu based on your child’s specific symptoms, not a mandatory set of appointments for every single child [3].
- Medical Genetics: Often the “anchor” of the team, geneticists confirm the diagnosis and provide counseling on the MAP2K1 mutation and recurrence risks [2].
- Pediatric Cardiology: Essential for identifying heart defects like pulmonary valve stenosis or hypertrophic cardiomyopathy. Long-term follow-up is necessary even if the first scan is clear [4].
- Pediatric Neurology: Evaluates for developmental delays and manages epilepsy, which is highly prevalent in children with MAP2K1 mutations [5].
- Gastroenterology and Nutrition: Manages feeding difficulties, reflux, and growth failure [6].
- Early Intervention Therapies: Physical Therapy (PT), Occupational Therapy (OT), and Speech/Feeding Therapy are critical for maximizing your child’s functional development.
- Pediatric Ophthalmology: Screens for vision issues like high myopia (nearsightedness) and astigmatism, which can lead to amblyopia (lazy eye) if not caught early [7].
- Audiology and ENT: Screens for sensorineural hearing loss. An ENT specialist monitors for airway structural issues [8].
- Immunology (Conditional): If your child has a history of severe or unusually recurrent infections, poor vaccine responses, or autoimmune features, a referral to immunology is warranted. Emerging evidence links some MAP2K1 mutations to hypogammaglobulinemia (low antibody levels), but universal baseline testing is not standard for all unless clinically indicated [9][10].
Special Considerations for Anesthesia
If your child requires surgery or a procedure involving sedation, an experienced pediatric anesthesiologist is critical. While not every child with CFC3 will have complications, the syndrome presents specific reported risks that the surgical team must prepare for [11].
- Airway Management: Some children have a “difficult airway” due to the shape of their jaw, or structural issues like laryngomalacia (floppy airway) [12].
- Respiratory Weakness: Potential underlying weakness in breathing muscles can increase the risk of complications after waking up [11].
- Pre-Surgical Planning: Create a portable Anesthesia Summary containing your child’s CFC diagnosis, cardiac status (with a recent echocardiogram), airway history, seizure history, and current medications. Ensure the anesthesiologist reviews this before elective procedures [11].
Vetting Your Care Team
Not every specialist will have experience with a rare condition like CFC. When building your team, do not be afraid to “interview” doctors to ensure they are the right fit. Seek professionals willing to collaborate, communicate with your other doctors, and consult national RASopathy experts if they encounter unfamiliar symptoms. If possible, an evaluation at a dedicated Multidisciplinary RASopathy Clinic can be invaluable [1][2].
Common questions in this guide
What kind of doctors does a child with CFC3 need?
Does my child need heart follow-up if the first echocardiogram is normal?
What should we tell the anesthesiologist before my child with CFC3 has surgery?
When should a child with CFC3 see an immunologist?
How often should CFC3 screenings be repeated when early results are normal?
How can we coordinate care for a child with CFC3?
Get notified when new evidence is published on cardiofaciocutaneous syndrome 3.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Cardio-facio-cutaneous syndrome and gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP 2 K2 gene.
Serra G, Felice S, Antona V, et al.
Italian journal of pediatrics 2022; (48(1)):65 doi:10.1186/s13052-022-01241-6.
PMID: 35509048 - 2
RASopathies: Dermatologists' viewpoints.
Palit A, Inamadar AC
Indian journal of dermatology, venereology and leprology 2022; (88(4)):452-463.
PMID: 35138057 - 3
Clinical and Molecular Portraits of Pediatric RASopathies: A Study of 118 Genotype-Confirmed Cases.
Genç A, Sarıkaya E, Ceylan AC, et al.
Clinical genetics 2026; (110(3)):299-314 doi:10.1111/cge.70193.
PMID: 42261585 - 4
Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies.
Jhang WK, Choi JH, Lee BH, et al.
Pediatric cardiology 2016; (37(8)):1539-1547 doi:10.1007/s00246-016-1468-6.
PMID: 27554254 - 5
Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study.
Pierpont EI, Kenney-Jung DL, Shanley R, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(7)):1556-1566 doi:10.1016/j.gim.2022.04.004.
PMID: 35524774 - 6
Management of nutritional and gastrointestinal issues in RASopathies: A narrative review.
Onesimo R, Giorgio V, Viscogliosi G, et al.
American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(4)):478-493 doi:10.1002/ajmg.c.32019.
PMID: 36515923 - 7
Systematic ophthalmologic evaluation in cardio-facio-cutaneous syndrome: A genotype-endophenotype correlation.
Crincoli E, Leoni C, Viscogliosi G, et al.
American journal of medical genetics. Part A 2023; (191(11)):2783-2792 doi:10.1002/ajmg.a.63395.
PMID: 37697822 - 8
Phoniatric, Audiological, Orodental and Speech Problems in a Boy with Cardio-Facio-Cutaneous Syndrome Type 3 (CFC 3) Due to a Pathogenic Variant in MAP2K1 - Case Study.
Kosztyła-Hojna B, Borys J, Zdrojkowski M, et al.
The application of clinical genetics 2021; (14()):389-398 doi:10.2147/TACG.S316215.
PMID: 34522120 - 9
Case report: The cardio-facio-cutaneous syndrome due to a novel germline mutation in MAP2K1: A multifaceted disease with immunodeficiency and short stature.
Szczawińska-Popłonyk A, Popłonyk N, Niedziela M, et al.
Frontiers in pediatrics 2022; (10()):990111 doi:10.3389/fped.2022.990111.
PMID: 36313893 - 10
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort.
Di Majo BE, Leoni C, Cartisano E, et al.
Frontiers in immunology 2025; (16()):1598896 doi:10.3389/fimmu.2025.1598896.
PMID: 40692796 - 11
Anesthetic Management of a Pediatric Patient With Cardiofaciocutaneous Syndrome.
Shionoya Y, Yamamoto M, Sunada K, Nakamura K
Anesthesia progress 2020; (67(1)):45-47 doi:10.2344/anpr-67-01-07.
PMID: 32191511 - 12
Anesthesia management of pediatric dentistry patients with cardiofaciocutaneous syndrome: a case report.
Gonnella GL, Giuri PP, Zanfini BA, et al.
Brazilian journal of anesthesiology (Elsevier) 2021; (71(2)):178-180 doi:10.1016/j.bjane.2020.10.013.
PMID: 33894861
This page is for informational purposes only and does not constitute medical advice about your child's CFC3 care. Your child's genetics, pediatric, and anesthesia teams should tailor referrals, screening, and procedure planning to the child's medical history.